• Explore /
  • Poster
  • / Neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial.

Neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial.

Abstract Poster

Authors

Pashtoon Kasi

Pashtoon Murtaza Kasi

Weill Cornell Medicine, Englander Institute of Precision Medicine, NewYork-Presbyterian Hospital, New York, NY

Pashtoon Murtaza Kasi , Mehraneh D. Jafari , Heather Yeo , Lea Lowenfeld , Uqba Khan , Alana Nguyen , Despina Siolas , Brandon Swed , Sahrish Khan , Madeleine Wood , Allyson J. Ocean , Elizabeta C. Popa , Kelly A. Garrett , Encouse Golden , Preethi Guniganti , Xi K. Zhou , Alessio Pigazzi , Manish A. Shah , Erika Hissong , Manuel Hidalgo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05571293

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 117)

DOI

10.1200/JCO.2024.42.3_suppl.117

Abstract #

117

Poster Bd #

H2

Abstract Disclosures

Similar Posters

First Author: Mashiro Okunaka

First Author: Sherise C. Rogers

First Author: Toshiharu Hirose

First Author: Mark R. Middleton